Send us a Message



 Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) RatMine GViewer (Genome Viewer) Overgo Probe Designer VCMap
Aging & Age-Related Disease Cancer Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
PhenoMiner Database Result        View data table  |  Download data table  |  View expanded data table        

Generate Chart For    
    (Chart displayed below)
Rat Strains
{{sample.term}}
Measurement Methods
{{method.term}}
Age
{{ageRange}}
Experimental Conditions
     {{ cond }}

Minimum Value:    Maximum Value:    Sex:


 
Options:  View chart  |  Download data table  |  View expanded data table
# of AnimalsPhenotypeStrainSexValueUnitsConditionsRecord IDCondition 1aCondition 1bCondition 2
48mammary tumor numberSPRD/Ztmfemale11.237,12-dimethyltetraphene (DMBA) (65 mg/kg) 113407,12-dimethyltetraphene (DMBA) (65 mg/kg)
48post-insult time to mammary tumor formationSPRD/Ztmfemale43.8d7,12-dimethyltetraphene (DMBA) (65 mg/kg) 113437,12-dimethyltetraphene (DMBA) (65 mg/kg)
48mammary tumor growth rateSPRD/Ztmfemale0.7cm/week7,12-dimethyltetraphene (DMBA) (65 mg/kg) 113467,12-dimethyltetraphene (DMBA) (65 mg/kg)
36mammary tumor growth rateSPRD.WKY-(D5Rat190-D5Rat114)(D18Rat102-D18Rat44)/Ibmmfemale0.37cm/week7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)113497,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)
25mammary tumor growth rateSPRD/Ztmfemale0.72cm/week7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)115097,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)
16mammary tumor growth rateSPRD.WKY-(D5Rat190-D5Rat114)/Ibmmfemale0.65cm/week7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)115107,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)
52mammary tumor growth rateSPRD.WKY-(D18Wox8-D18Rat44)/Ibmmfemale0.73cm/week7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)115117,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)
33mammary tumor growth rateSPRD.WKY-(D10Rat91-D10Rat135)/Ibmmfemale0.53cm/week7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)115127,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)
46mammary tumor growth rateSPRD.WKY-(D18Wox8-D18Rat44)/Ibmmfemale0.79cm/week7,12-dimethyltetraphene (DMBA) (65 mg/kg) 113487,12-dimethyltetraphene (DMBA) (65 mg/kg)
14mammary tumor growth rateSPRD.WKY-(D5Rat190-D5Rat114)/Ibmmfemale0.62cm/week7,12-dimethyltetraphene (DMBA) (65 mg/kg) 113477,12-dimethyltetraphene (DMBA) (65 mg/kg)
17mammary tumor numberWKY/NHsdfemale07,12-dimethyltetraphene (DMBA) (65 mg/kg) 117417,12-dimethyltetraphene (DMBA) (65 mg/kg)
21mammary tumor numberWF/NHsdfemale7.37,12-dimethyltetraphene (DMBA) (65 mg/kg) 117427,12-dimethyltetraphene (DMBA) (65 mg/kg)
50mammary tumor numberWF/NHsdfemale6.97,12-dimethyltetraphene (DMBA) (65 mg/kg) 117437,12-dimethyltetraphene (DMBA) (65 mg/kg)
13mammary tumor numberWF.WKY-(D5Wox7-D5Uwm37)/Uwmfemale1.17,12-dimethyltetraphene (DMBA) (65 mg/kg) 117447,12-dimethyltetraphene (DMBA) (65 mg/kg)
29mammary tumor numberWF.WKY-(D5Rat26-D5Uwm42)/Uwmfemale5.77,12-dimethyltetraphene (DMBA) (65 mg/kg) 117457,12-dimethyltetraphene (DMBA) (65 mg/kg)
30mammary tumor numberWF/NHsdfemale8.17,12-dimethyltetraphene (DMBA) (65 mg/kg) 117467,12-dimethyltetraphene (DMBA) (65 mg/kg)
16mammary tumor numberCOP/OlaHsdfemale0.257,12-dimethyltetraphene (DMBA) (65 mg/kg) 117477,12-dimethyltetraphene (DMBA) (65 mg/kg)
46post-insult time to mammary tumor formationSPRD.WKY-(D18Wox8-D18Rat44)/Ibmmfemale45.91d7,12-dimethyltetraphene (DMBA) (65 mg/kg) 113457,12-dimethyltetraphene (DMBA) (65 mg/kg)
14post-insult time to mammary tumor formationSPRD.WKY-(D5Rat190-D5Rat114)/Ibmmfemale53.4d7,12-dimethyltetraphene (DMBA) (65 mg/kg) 113447,12-dimethyltetraphene (DMBA) (65 mg/kg)
14mammary tumor numberSS-Chr 19BN/Mcwifemale8.797,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)115077,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
13mammary tumor numberSS-Chr 16BN/Mcwifemale6.317,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)115047,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
13mammary tumor numberSS-Chr 13BN/Mcwifemale5.337,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)115017,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
40percentage of study population developing mammary tumors during a period of timeSS-Chr 9BN/Mcwifemale93%7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)114957,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
20percentage of study population developing mammary tumors during a period of timeSS-Chr 6BN/Mcwifemale20%7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)114947,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
13percentage of study population developing mammary tumors during a period of timeSS-Chr 5BN/Mcwifemale54%7,12-dimethyltetraphene (DMBA) (65 g/kg) (for 105 days)114937,12-dimethyltetraphene (DMBA) (65 g/kg) (for 105 days)
14post-insult time to mammary tumor formationSS-Chr 3BN/Mcwifemale95.48d7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)114917,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
40mammary tumor numberSS/JrHsdMcwifemale2.457,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)114887,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
25mammary tumor numberSPRD.WKY-(D10Rat91-D10Rat135)/Ibmmfemale9.247,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)113577,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)
46mammary tumor numberSPRD.WKY-(D18Wox8-D18Rat44)/Ibmmfemale7.617,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)113567,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)
14mammary tumor numberSPRD.WKY-(D5Rat190-D5Rat114)/Ibmmfemale3.937,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)113557,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)
17mammary tumor numberSPRD/Ztmfemale10.897,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)113547,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)
33mammary tumor numberSPRD.WKY-(D5Rat190-D5Rat114)(D18Rat102-D18Rat44)/Ibmmfemale57,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)113587,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)
46mammary tumor numberSPRD.WKY-(D18Wox8-D18Rat44)/Ibmmfemale7.617,12-dimethyltetraphene (DMBA) (65 mg/kg) 113427,12-dimethyltetraphene (DMBA) (65 mg/kg)
14mammary tumor numberSPRD.WKY-(D5Rat190-D5Rat114)/Ibmmfemale3.937,12-dimethyltetraphene (DMBA) (65 mg/kg) 113417,12-dimethyltetraphene (DMBA) (65 mg/kg)
14post-insult time to mammary tumor formationSS.BN-(D13Hmgc64-RN34_13048990782)/Mcwifemale48.51d7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)655727,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
14mammary tumor numberSS.BN-(D13Hmgc64-RN34_13048990782)/Mcwifemale4.867,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)655737,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
14post-insult time to mammary tumor formationSS.BN-(D6Rat149-D6Arb3)/Mcwifemale52.37d7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)655747,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
14ratio of deaths related to DMBA toxicity to total study population during a period of timeSS.BN-(D6Rat149-D6Arb3)/Mcwifemale57%7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)655757,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
15ratio of deaths related to DMBA toxicity to total study population during a period of timeSS.BN-(D6Rat149-D6Rat18)/Mcwifemale80%7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)655767,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
15ratio of deaths related to DMBA toxicity to total study population during a period of timeSS.BN-(D6Rat149-D6Got171)/Mcwifemale40%7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)655777,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
20ratio of deaths related to DMBA toxicity to total study population during a period of timeSS-Chr 6BN/Mcwifemale95%7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)655787,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
53mammary tumor numberWFfemale3.627,12-dimethyltetraphene (DMBA) (65 mg/kg) (between 126 and 140 days)661007,12-dimethyltetraphene (DMBA) (65 mg/kg) (between 126 and 140 days)
14percentage of study population developing mammary tumors during a period of timeSS-Chr 3BN/Mcwifemale29%7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)655667,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
40post-insult time to mammary tumor formationSS-Chr 9BN/Mcwifemale58.31d7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)655677,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
40post-insult time to mammary tumor formationSS/JrHsdMcwifemale79.8d7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)655687,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
14post-insult time to mammary tumor formationSS-Chr 19BN/Mcwifemale44.03d7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)655697,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
14post-insult time to mammary tumor formationSS-Chr 14BN/Mcwifemale46.69d7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)655707,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
14mammary tumor numberSS.BN-(D6Rat149-D6Arb3)/Mcwifemale4.777,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)655717,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
32mammary tumor numberWF.WKY-(D7Rat171-D7Rat128)/2Uwmfemale3.97,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)660617,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
17mammary tumor numberWF.WKY-(D7Rat171-D7Rat128)/1Uwmfemale3.57,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)660607,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
23mammary tumor numberWF.WKY-(D7Rat51-D7Rat128)/Uwmfemale87,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)660627,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
43mammary tumor numberWF.WKY-(D7Uwm25-D7Rat128)/Uwmfemale7.27,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)660637,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
28mammary tumor numberWF.WKY-(D7Rat171-D7Rat45)/Uwmfemale3.47,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)660647,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
16mammary tumor numberWF.COP-(D7Rat39-D7Uwm12)/1Uwmfemale2.47,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)660657,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
16mammary tumor numberWF.COP-(D7Rat39-D7Uwm12)/2Uwmfemale27,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)660667,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
19mammary tumor numberWFfemale7.37,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)660677,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
29mammary tumor numberWF/NHsdfemale6.37,12-dimethyltetraphene (DMBA) (65 mg/kg) 701677,12-dimethyltetraphene (DMBA) (65 mg/kg)
19mammary tumor numberWF.COP-(D2Mit29-D2Rat201)/Uwmfemale1.57,12-dimethyltetraphene (DMBA) (65 mg/kg) 701687,12-dimethyltetraphene (DMBA) (65 mg/kg)
35mammary tumor numberWF.WKY-(D5Uwm67-D5Uwm98)/Uwmfemale3.27,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)702967,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
40mammary tumor numberWF.WKY-(D5Uwm76-D5Uwm61)/Uwmfemale4.27,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)702977,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
26mammary tumor numberWF.WKY-(D5Uwm76-D5Uwm98)/Uwmfemale3.87,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)702987,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
32mammary tumor numberWF.WKY-(D5Uwm67-D5Uwm78)/Uwmfemale8.67,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)702997,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
27mammary tumor numberWF.WKY-(D5Uwm76-D5Got18)/Uwmfemale3.57,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)703007,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
32mammary tumor numberWF.WKY-(D5Uwm78-D5Uwm98)/Uwmfemale2.87,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)703017,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
36mammary tumor numberWF.WKY-(D5Uwm95-D5Uwm98)/Uwmfemale7.47,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)703027,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
26mammary tumor numberWF.WKY-(D5Uwm67-D5Uwm81)/Uwmfemale8.37,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)703037,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
58mammary tumor numberWF.WKY-(D5Uwm76-D5Uwm92)/Uwmfemale4.87,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)703047,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
29mammary tumor numberWF.WKY-(D5Uwm78-D5Uwm84)/Uwmfemale8.87,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)703057,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
27mammary tumor numberWF.WKY-(D5Uwm78-D5Uwm93)/Uwmfemale57,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)703067,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
41mammary tumor numberWF.WKY-(D5Uwm78-D5Uwm84)/Uwmfemale8.17,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)703077,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
58mammary tumor numberWF.WKY-(D5Uwm88-D5Uwm92)/Uwmfemale6.97,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)703087,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
56mammary tumor numberWF.WKY-(D5Uwm87-D5Uwm92)/Uwmfemale6.37,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)703097,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
51mammary tumor numberWF.WKY-(D5Uwm85-D5Uwm92)/Uwmfemale3.97,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)703107,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
18mammary tumor numberWF.WKY-(D5Uwm82-D5Uwm92)/Uwmfemale2.67,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)703117,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
58mammary tumor numberWF.WKY-(D5Uwm82-D5Uwm91)/Uwmfemale3.47,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)703127,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
12mammary tumor numberWF.WKY-(D5Uwm77-D5Uwm91)/Uwmfemale3.87,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)703137,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
46mammary tumor numberWF/NHsdfemale7.97,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)703147,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
32mammary tumor numberCrl:CD(SD)female2.84maternal milk (for 20 days) and vehicle control condition (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days)76264maternal milk (for 20 days)vehicle control condition (for 15 days)7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days)
34mammary tumor numberCrl:CD(SD)female3.82maternal milk (for 20 days) and bisphenol A (25 ug/kg) (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days)76265maternal milk (for 20 days)bisphenol A (25 ug/kg) (for 15 days)7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days)
24mammary tumor numberCrl:CD(SD)female5maternal milk (for 20 days) and bisphenol A (250 ug/kg) (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days)76266maternal milk (for 20 days)bisphenol A (250 ug/kg) (for 15 days)7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days)
32post-insult time to mammary tumor formationCrl:CD(SD)female65dmaternal milk (for 20 days) and vehicle control condition (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days)76267maternal milk (for 20 days)vehicle control condition (for 15 days)7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days)
34post-insult time to mammary tumor formationCrl:CD(SD)female53dmaternal milk (for 20 days) and bisphenol A (25 ug/kg) (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days)76268maternal milk (for 20 days)bisphenol A (25 ug/kg) (for 15 days)7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days)
24post-insult time to mammary tumor formationCrl:CD(SD)female56.5dmaternal milk (for 20 days) and bisphenol A (250 ug/kg) (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days)76269maternal milk (for 20 days)bisphenol A (250 ug/kg) (for 15 days)7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days)

Contact Us |  About Us |  Jobs at RGD